Assessing State, Federal Legislation Alignment With Expansion of Pharmacist’s Role on Care Team
May 4th 2022Tracy Russell, senior director, State Government Affairs at CoverMyMeds, discusses her presentation at Asembia Summit 2022 on legislation aligned with the movement to expand the pharmacist’s role on the care team.
Expert: Specialty Approvals Pharmacists Should Look for on the Horizon
May 4th 2022Ray Tancredi, divisional vice president of Specialty Pharmacy, Development & Brand Rx/Vaccine Purchasing at Walgreens, addresses his presentation on the specialty pharmaceutical pipeline, and specifically what approvals pharmacists should look for on the horizon.
Overview of the Most Significant Drugs in Specialty Pharmacy FDA Pipeline in 2022
May 3rd 2022Ray Tancredi, divisional vice president of Specialty Pharmacy, Development & Brand Rx/Vaccine Purchasing at Walgreens, discusses some of the more significant drugs for specialty pharmacy in the FDA pipeline this year.
Walgreens Launches Fertility Awareness Campaign in Support of National Infertility Awareness Week
April 22nd 2022Laly Havern, PharmD, MS, BCACP, director in specialty health solutions leading in oncology and fertility at Walgreens, discusses the company's Fertility Awareness Campaign that is being launched as part of National Infertility Awareness Week.
NIH Distinguished Investigator Discusses Impact of Pandemic on Diversity in the Workplace
April 22nd 2022Elaine Jaffe, MD, National Institutes of Health (NIH) distinguished investigator at the National Cancer Institute at NIH, offers guidance for female medical researchers who are faced with a declining number of female colleagues in the workforce.
How Classification of Lymphoma in the Modern Era Impacted Patient Treatment, Patient Care
April 21st 2022Elaine Jaffe, MD, National Institutes of Health (NIH) distinguished investigator at the National Cancer Institute at NIH, discusses where she sees the classification of lymphoma progressing in the coming years.
NIH Distinguished Investigator Discusses the Evolution of Lymphoma Classification
April 19th 2022Elaine Jaffe, MD, National Institutes of Health (NIH) distinguished investigator at the National Cancer Institute at NIH, discusses points of note in the evolution of lymphoma classification during her clinical and investigational research on the subject.